EyePoint Pharmaceuticals (EYPT)

• Market cap: $346M
• 1 day: -7.20%
• 5 days: -19.00%
• 1 month: -12.06%
• 3 months: -37.36%
• 6 months: -37.13%
• Year to date: -37.36%
• 1 year: -75.19%
• 5 years: -41.51%
• 10 years: -86.94%
• Sector: Industrials
• Industry: Laboratory Analytical Instruments

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

154% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 26

33% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 21

15% more capital invested

Capital invested by funds: $479M [Q3] → $551M (+$72.2M) [Q4]

4% more funds holding

Funds holding: 138 [Q3] → 144 (+6) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 3 [Q3] → 3 (+0) [Q4]

7% less call options, than puts

Call options by funds: $2.28M | Put options by funds: $2.46M

1.34% less ownership

Funds ownership: 110.0% [Q3] → 108.66% (-1.34%) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $22 337% upside
• Avg. target: $29 483% upside
• High target: $33 556% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Chardan Capital Daniil Gataulin 27% 1-year accuracy 12 / 45 met price target	556% upside $33	Buy Maintained	6 Mar 2025
HC Wainwright & Co. Yi Chen 38% 1-year accuracy 63 / 167 met price target	337% upside $22	Buy Reiterated	6 Mar 2025
Citigroup Yigal Nochomovitz 16% 1-year accuracy 7 / 43 met price target	556% upside $33	Buy Initiated	7 Jan 2025